Skip to main content
Top
Published in: Virology Journal 1/2008

Open Access 01-12-2008 | Research

Comparison of p53 and the PDZ domain containing protein MAGI-3 regulation by the E6 protein from high-risk human papillomaviruses

Authors: Julia Ainsworth, Miranda Thomas, Lawrence Banks, Francois Coutlee, Greg Matlashewski

Published in: Virology Journal | Issue 1/2008

Login to get access

Abstract

Central to cellular transformation caused by human papillomaviruses (HPVs) is the ability of E6 proteins to target cellular p53 and proteins containing PDZ domains, including MAGI-3, for degradation. The aim of this study was to compare E6-mediated degradation of p53 and MAGI-3 under parallel experimental conditions and further with respect to the involvement of proteasomes and ubiquitination. We also compared the degradation of p53 and MAGI-3 by E6 from several HPV types including different variants from HPV-33. All of the E6 genes from different HPV types displayed similar abilities to mediate the degradation of both p53 and MAGI-3 although there may be subtle differences observed with the different 33E6 variants. There were however differences in E6 mediated degradation of p53 and MAGI-3. Proteasome inhibition assays partially protected p53 from E6 mediated degradation, but did not protect MAGI-3. In addition, under conditions where p53 was ubiquitinated by E6 and MDM2 in vivo, ubiquitination of MAGI-3 was not detected. These results imply that although both p53 and MAGI-3 represent effective targets for oncogenic E6, the mechanisms by which E6 mediates p53 and MAGI-3 degradation are distinct with respect to the involvement of ubiquitination prior to proteasomal degradation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Munoz N, Bosch F, de Sanjose S, Herrero X, Castellsague X, Shah V, Snijders P, Meijer C: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003, 348: 518-527. 10.1056/NEJMoa021641CrossRefPubMed Munoz N, Bosch F, de Sanjose S, Herrero X, Castellsague X, Shah V, Snijders P, Meijer C: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003, 348: 518-527. 10.1056/NEJMoa021641CrossRefPubMed
2.
go back to reference Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S: Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003, 88: 63-73. 10.1038/sj.bjc.6600688PubMedCentralCrossRefPubMed Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S: Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003, 88: 63-73. 10.1038/sj.bjc.6600688PubMedCentralCrossRefPubMed
3.
go back to reference Wise-Draper T, Wells S: Papillomavirus E6 and E7 proteins and their cellular targets. Front Biosci 2008, 13: 1003-1017. 10.2741/2739CrossRefPubMed Wise-Draper T, Wells S: Papillomavirus E6 and E7 proteins and their cellular targets. Front Biosci 2008, 13: 1003-1017. 10.2741/2739CrossRefPubMed
4.
go back to reference Vousden K, Lane D: p53 in Health and Disease. Nat Rev Mel Cell Biol 2007,8(4):275-283. 10.1038/nrm2147CrossRef Vousden K, Lane D: p53 in Health and Disease. Nat Rev Mel Cell Biol 2007,8(4):275-283. 10.1038/nrm2147CrossRef
5.
go back to reference Stewart D, Ghosh A, Matlashewski G: Involvement of nuclear export in human papillomavirus type 18 E6-mediated ubiquitination and degradation of p53. J Virol 2005, 79: 8773-8783. 10.1128/JVI.79.14.8773-8783.2005PubMedCentralCrossRefPubMed Stewart D, Ghosh A, Matlashewski G: Involvement of nuclear export in human papillomavirus type 18 E6-mediated ubiquitination and degradation of p53. J Virol 2005, 79: 8773-8783. 10.1128/JVI.79.14.8773-8783.2005PubMedCentralCrossRefPubMed
7.
go back to reference Massimi P, Shai A, Lambert P, Banks L: HPV E6 degradation of p53 and PDZ containing substrates in an E6AP null background. Oncogene 2007, 26: 1-5. 10.1038/sj.onc.1209759CrossRef Massimi P, Shai A, Lambert P, Banks L: HPV E6 degradation of p53 and PDZ containing substrates in an E6AP null background. Oncogene 2007, 26: 1-5. 10.1038/sj.onc.1209759CrossRef
8.
go back to reference Camus S, Menendez S, Cheok CF, Stevenson LF, Lain S, Lane D: Ubiquitin-independent degradation of p53 mediated by high-risk human papillomavirus protein E6. Oncogene 2007, 26: 4059-4070. 10.1038/sj.onc.1210188PubMedCentralCrossRefPubMed Camus S, Menendez S, Cheok CF, Stevenson LF, Lain S, Lane D: Ubiquitin-independent degradation of p53 mediated by high-risk human papillomavirus protein E6. Oncogene 2007, 26: 4059-4070. 10.1038/sj.onc.1210188PubMedCentralCrossRefPubMed
9.
go back to reference Shai A, Nguyen M, Wagstaff J, Jiang Y, Lambert P: HPV16 E6 confers p53-dependent and p53-independent phenotypes in the epidermis of mice deficient for E6AP. Oncogene 2007, 26: 3321-3328. 10.1038/sj.onc.1210130PubMedCentralCrossRefPubMed Shai A, Nguyen M, Wagstaff J, Jiang Y, Lambert P: HPV16 E6 confers p53-dependent and p53-independent phenotypes in the epidermis of mice deficient for E6AP. Oncogene 2007, 26: 3321-3328. 10.1038/sj.onc.1210130PubMedCentralCrossRefPubMed
10.
go back to reference Dev K: Making protein interactions druggable: targeting PDZ domains. Nat Rev Drug Discov 2004, 3: 1047-1053. 10.1038/nrd1578CrossRefPubMed Dev K: Making protein interactions druggable: targeting PDZ domains. Nat Rev Drug Discov 2004, 3: 1047-1053. 10.1038/nrd1578CrossRefPubMed
11.
go back to reference Fanning AS, Anderson JM: PDZ domains: fundamental building blocks in the organization of protein complexes at the plasma membrane. J Clin Invest 1999, 103: 767-772. 10.1172/JCI6509PubMedCentralCrossRefPubMed Fanning AS, Anderson JM: PDZ domains: fundamental building blocks in the organization of protein complexes at the plasma membrane. J Clin Invest 1999, 103: 767-772. 10.1172/JCI6509PubMedCentralCrossRefPubMed
12.
go back to reference Kuhlendahl S, Spangenberg O, Konrad M, Kim E, Garner C: Functional analysis of the guanylate kinase-like domain in the synapse-associated protein SAP97. Eur J Biochem 1998, 252: 305-313. 10.1046/j.1432-1327.1998.2520305.xCrossRefPubMed Kuhlendahl S, Spangenberg O, Konrad M, Kim E, Garner C: Functional analysis of the guanylate kinase-like domain in the synapse-associated protein SAP97. Eur J Biochem 1998, 252: 305-313. 10.1046/j.1432-1327.1998.2520305.xCrossRefPubMed
13.
go back to reference Montgomery JM, Zamorano PL, Garner C: MAGUKs in synapse assembly and function: an emerging view. Cell Mol Life Sci 2004, 61: 911-929. 10.1007/s00018-003-3364-5CrossRefPubMed Montgomery JM, Zamorano PL, Garner C: MAGUKs in synapse assembly and function: an emerging view. Cell Mol Life Sci 2004, 61: 911-929. 10.1007/s00018-003-3364-5CrossRefPubMed
14.
go back to reference Laura RP, Ross S, Koeppen H, Lasky L: MAGI-1: a widely expressed, alternatively spliced tight junction protein. Exp Cell Res 2002, 275: 155-170. 10.1006/excr.2002.5475CrossRefPubMed Laura RP, Ross S, Koeppen H, Lasky L: MAGI-1: a widely expressed, alternatively spliced tight junction protein. Exp Cell Res 2002, 275: 155-170. 10.1006/excr.2002.5475CrossRefPubMed
15.
go back to reference Iida J, Hirabayashi S, Sato Y, Hata Y: Synaptic scaffolding molecule is involved in the synaptic clustering of neuroligin. Mol Cell Neurosci 2004, 27: 497-508. 10.1016/j.mcn.2004.08.006CrossRefPubMed Iida J, Hirabayashi S, Sato Y, Hata Y: Synaptic scaffolding molecule is involved in the synaptic clustering of neuroligin. Mol Cell Neurosci 2004, 27: 497-508. 10.1016/j.mcn.2004.08.006CrossRefPubMed
16.
go back to reference Kotelevets L, van Hengel J, Bruyneel E, Mareel M, van Roy F, Chastre E: Implication of the MAGI-1b/PTEN signalosome in stabilization of adherens junctions and suppression of invasiveness. FASEB J 2005, 19: 115-7.PubMed Kotelevets L, van Hengel J, Bruyneel E, Mareel M, van Roy F, Chastre E: Implication of the MAGI-1b/PTEN signalosome in stabilization of adherens junctions and suppression of invasiveness. FASEB J 2005, 19: 115-7.PubMed
17.
go back to reference Wu X, Hepner K, Castelino-Prabhu S, Do D, Kaye MB, Yuan XJ, Wood J, Ross C, Sawyers CL, Whang YE: Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2. Proc Natl Acad Sci USA 2000, 97: 4233-4238. 10.1073/pnas.97.8.4233PubMedCentralCrossRefPubMed Wu X, Hepner K, Castelino-Prabhu S, Do D, Kaye MB, Yuan XJ, Wood J, Ross C, Sawyers CL, Whang YE: Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2. Proc Natl Acad Sci USA 2000, 97: 4233-4238. 10.1073/pnas.97.8.4233PubMedCentralCrossRefPubMed
18.
go back to reference Wu Y, Dowbenko D, Spencer S, Laura R, Lee J, Gu Q, Lasky LA: Interaction of the tumor suppressor PTEN/MMAC with a PDZ domain of MAGI3, a novel membrane-associated guanylate kinase. J Biol Chem 2000, 275: 21477-21485. 10.1074/jbc.M909741199CrossRefPubMed Wu Y, Dowbenko D, Spencer S, Laura R, Lee J, Gu Q, Lasky LA: Interaction of the tumor suppressor PTEN/MMAC with a PDZ domain of MAGI3, a novel membrane-associated guanylate kinase. J Biol Chem 2000, 275: 21477-21485. 10.1074/jbc.M909741199CrossRefPubMed
19.
go back to reference Gardiol D, Kuhne C, Glaunsinger B, Lee S, Javier R, Banks L: Oncogenic human papillomavirus E6 protein targets the discs large tumour suppressor for proteasome-mediated degradation. Oncogene 1999, 18: 5487-5496. 10.1038/sj.onc.1202920CrossRefPubMed Gardiol D, Kuhne C, Glaunsinger B, Lee S, Javier R, Banks L: Oncogenic human papillomavirus E6 protein targets the discs large tumour suppressor for proteasome-mediated degradation. Oncogene 1999, 18: 5487-5496. 10.1038/sj.onc.1202920CrossRefPubMed
20.
go back to reference Thomas M, Laura R, Hepner K, Guccione E, Sawyers C, Lasky L, Banks L: Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation. Oncogene 2002, 21: 5088-5096. 10.1038/sj.onc.1205668CrossRefPubMed Thomas M, Laura R, Hepner K, Guccione E, Sawyers C, Lasky L, Banks L: Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation. Oncogene 2002, 21: 5088-5096. 10.1038/sj.onc.1205668CrossRefPubMed
21.
go back to reference Lee SS, Glaunsinger B, Mantovani F, Banks L, Javier RT: Multi-PDZ domain protein MUPP1 is a cellular target for both adenovirus E4-ORF1 and high-risk papillomavirus type 18 E6 oncoproteins. J Virol 2000, 74: 9680-9693. 10.1128/JVI.74.20.9680-9693.2000PubMedCentralCrossRefPubMed Lee SS, Glaunsinger B, Mantovani F, Banks L, Javier RT: Multi-PDZ domain protein MUPP1 is a cellular target for both adenovirus E4-ORF1 and high-risk papillomavirus type 18 E6 oncoproteins. J Virol 2000, 74: 9680-9693. 10.1128/JVI.74.20.9680-9693.2000PubMedCentralCrossRefPubMed
22.
go back to reference Massimi P, Gammoh N, Thomas M, Banks L: HPV E6 specifically targets different cellular pools of its PDZ domain-containing tumour suppressor substrates fro proteasome-mediated degradation. Oncogene 2004, 23: 8033-8039. 10.1038/sj.onc.1207977CrossRefPubMed Massimi P, Gammoh N, Thomas M, Banks L: HPV E6 specifically targets different cellular pools of its PDZ domain-containing tumour suppressor substrates fro proteasome-mediated degradation. Oncogene 2004, 23: 8033-8039. 10.1038/sj.onc.1207977CrossRefPubMed
23.
go back to reference Zhang Y, Dasgupta J, Ma RZ, Banks L, Thomas M, Chen XS: Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: mechanisms of targeting tumor suppressors by a high-risk HPV oncoprotein. J Virol 2007, 81: 3618-3626. 10.1128/JVI.02044-06PubMedCentralCrossRefPubMed Zhang Y, Dasgupta J, Ma RZ, Banks L, Thomas M, Chen XS: Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: mechanisms of targeting tumor suppressors by a high-risk HPV oncoprotein. J Virol 2007, 81: 3618-3626. 10.1128/JVI.02044-06PubMedCentralCrossRefPubMed
24.
go back to reference Simonson S, Difilippantonio M, Lambert P: Two distinct activities contribute to human papillomavirus 16 E6's oncogenic potential. Cancer Res 2005, 65: 8266-8273. 10.1158/0008-5472.CAN-05-1651CrossRefPubMed Simonson S, Difilippantonio M, Lambert P: Two distinct activities contribute to human papillomavirus 16 E6's oncogenic potential. Cancer Res 2005, 65: 8266-8273. 10.1158/0008-5472.CAN-05-1651CrossRefPubMed
25.
go back to reference Kuballa P, Matentzoglu K, Scheffner M: The role of the ubiquitin ligase E6-AP in human papillomavirus E6-mediated degradation of PDZ domain-containing proteins. J Biol Chem 2007, 282: 65-71. 10.1074/jbc.M605117200CrossRefPubMed Kuballa P, Matentzoglu K, Scheffner M: The role of the ubiquitin ligase E6-AP in human papillomavirus E6-mediated degradation of PDZ domain-containing proteins. J Biol Chem 2007, 282: 65-71. 10.1074/jbc.M605117200CrossRefPubMed
26.
go back to reference Stewart D, Kazemi S, Li S, Massimi P, Banks L, Koromilas AE, Matlashewski G: Ubiquitination and proteasome degradation of the E6 proteins of human papillomavirus types 11 and 18. J Gen Virol 2004, 85: 1419-1426. 10.1099/vir.0.19679-0CrossRefPubMed Stewart D, Kazemi S, Li S, Massimi P, Banks L, Koromilas AE, Matlashewski G: Ubiquitination and proteasome degradation of the E6 proteins of human papillomavirus types 11 and 18. J Gen Virol 2004, 85: 1419-1426. 10.1099/vir.0.19679-0CrossRefPubMed
27.
go back to reference Khouadri S, Villa LL, Gagnon S, Koushik A, Richardson H, Ferreira S, Tellier P, Simao J, Matlashewski G, Roger M, Franco EL, Coutlee F: Human papillomavirus type 33 polymorphisms and high-grade squamous intraepithelial lesions of the uterine cervix. J Infect Dis 2006, 194: 886-894. 10.1086/507431CrossRefPubMed Khouadri S, Villa LL, Gagnon S, Koushik A, Richardson H, Ferreira S, Tellier P, Simao J, Matlashewski G, Roger M, Franco EL, Coutlee F: Human papillomavirus type 33 polymorphisms and high-grade squamous intraepithelial lesions of the uterine cervix. J Infect Dis 2006, 194: 886-894. 10.1086/507431CrossRefPubMed
28.
go back to reference Yan W, Dowbenko D, Spencer S, Laura R, Lee J, Gu Q, Lasky L: Interaction of the Tumor Suppressor PTEN/MMAC with a PDZ Domain of MAGI3, a Novel Membrane-associated Guanylate Kinase. J Biol Chem 2000, 275: 21477-21485. 10.1074/jbc.M909741199CrossRef Yan W, Dowbenko D, Spencer S, Laura R, Lee J, Gu Q, Lasky L: Interaction of the Tumor Suppressor PTEN/MMAC with a PDZ Domain of MAGI3, a Novel Membrane-associated Guanylate Kinase. J Biol Chem 2000, 275: 21477-21485. 10.1074/jbc.M909741199CrossRef
Metadata
Title
Comparison of p53 and the PDZ domain containing protein MAGI-3 regulation by the E6 protein from high-risk human papillomaviruses
Authors
Julia Ainsworth
Miranda Thomas
Lawrence Banks
Francois Coutlee
Greg Matlashewski
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2008
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-5-67

Other articles of this Issue 1/2008

Virology Journal 1/2008 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.